N, G., & L, B. (2021). Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press.
Style de citation Chicago (17e éd.)N, Giustini, et Bazhenova L. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press, 2021.
Style de citation MLA (8e éd.)N, Giustini, et Bazhenova L. Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs). Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.